Lisong Ni

1.0k total citations
28 papers, 825 citations indexed

About

Lisong Ni is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Lisong Ni has authored 28 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in Lisong Ni's work include Nicotinic Acetylcholine Receptors Study (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Lisong Ni is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Lisong Ni collaborates with scholars based in United States, China and Japan. Lisong Ni's co-authors include Edward F. Domino, Jon‐Kar Zubieta, Sally K. Guthrie, Robert A. Koeppe, Mary M. Heitzeg, Satoshi Minoshima, Edward F. Domino, Yanjun Xu, David Scott and Tiffany Love and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Lisong Ni

27 papers receiving 806 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisong Ni United States 14 352 308 199 169 107 28 825
Elaine Setiawan Canada 15 191 0.5× 162 0.5× 102 0.5× 150 0.9× 69 0.6× 16 1.3k
Jacqueline Borg Sweden 18 306 0.9× 169 0.5× 283 1.4× 93 0.6× 109 1.0× 37 995
Mayada Akil United States 14 514 1.5× 355 1.2× 355 1.8× 83 0.5× 38 0.4× 22 1.1k
Abigail G. Schindler United States 18 611 1.7× 366 1.2× 126 0.6× 106 0.6× 36 0.3× 35 1.1k
Jolanta Kucharska–Mazur Poland 19 207 0.6× 258 0.8× 113 0.6× 130 0.8× 106 1.0× 70 987
Mingkuan Lin United States 14 103 0.3× 151 0.5× 125 0.6× 125 0.7× 94 0.9× 22 719
Christoph von der Goltz Germany 19 386 1.1× 144 0.5× 465 2.3× 203 1.2× 241 2.3× 33 1.1k
Koichi Isogawa Japan 19 323 0.9× 146 0.5× 137 0.7× 152 0.9× 104 1.0× 40 938
Terrence Sills Canada 20 381 1.1× 181 0.6× 141 0.7× 54 0.3× 135 1.3× 36 968
P. Vivien Rekkas Canada 9 126 0.4× 105 0.3× 221 1.1× 87 0.5× 78 0.7× 14 1.1k

Countries citing papers authored by Lisong Ni

Since Specialization
Citations

This map shows the geographic impact of Lisong Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisong Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisong Ni more than expected).

Fields of papers citing papers by Lisong Ni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisong Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisong Ni. The network helps show where Lisong Ni may publish in the future.

Co-authorship network of co-authors of Lisong Ni

This figure shows the co-authorship network connecting the top 25 collaborators of Lisong Ni. A scholar is included among the top collaborators of Lisong Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisong Ni. Lisong Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhiwei, Ming‐Cheng Luo, Lisong Ni, et al.. (2025). The molecular mechanisms underlying Glabridin enhancing the topical permeability and anti-melanogenic effect of α-arbutin. Journal of Drug Delivery Science and Technology. 112. 107309–107309. 1 indexed citations
2.
Ni, Lisong, et al.. (2016). Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 69. 69–77. 23 indexed citations
3.
Domino, Edward F., et al.. (2015). Regional brain [ 11 C]carfentanil binding following tobacco smoking. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 59. 100–104. 18 indexed citations
4.
Hsu, David T., Benjamin Sanford, Kortni K. Meyers, et al.. (2013). Social feedback activates the endogenous opioid system. Molecular Psychiatry. 18(11). 1147–1147. 8 indexed citations
5.
Hsu, David T., Benjamin Sanford, Kortni K. Meyers, et al.. (2013). Response of the μ-opioid system to social rejection and acceptance. Molecular Psychiatry. 18(11). 1211–1217. 173 indexed citations
6.
Domino, Edward F., et al.. (2012). Tobacco smoking produces greater striatal dopamine release in G-allele carriers with mu opioid receptor A118G polymorphism. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 38(2). 236–240. 34 indexed citations
7.
Ni, Lisong, et al.. (2010). Venous plasma nicotine correlates of hormonal effects of tobacco smoking. Pharmacology Biochemistry and Behavior. 95(2). 209–215. 33 indexed citations
8.
Domino, Edward F., et al.. (2009). Tobacco smoking produces widespread dominant brain wave alpha frequency increases. International Journal of Psychophysiology. 74(3). 192–198. 32 indexed citations
9.
Domino, Edward F. & Lisong Ni. (2008). Biperiden enhances L-DOPA methyl ester and dopamine Dl receptor agonist SKF-82958 but antagonizes D2/D3 receptor agonist rotigotine antihemiparkinsonian actions. European Journal of Pharmacology. 599(1-3). 81–85. 5 indexed citations
10.
Scott, David, Edward F. Domino, Mary M. Heitzeg, et al.. (2006). Smoking Modulation of μ-Opioid and Dopamine D2 Receptor-Mediated Neurotransmission in Humans. Neuropsychopharmacology. 32(2). 450–457. 99 indexed citations
11.
Guthrie, Sally K., Lisong Ni, Jon‐Kar Zubieta, Christian J. Teter, & Edward F. Domino. (2004). Changes in craving for a cigarette and arterial nicotine plasma concentrations in abstinent smokers. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(4). 617–623. 16 indexed citations
12.
Domino, Edward F., et al.. (2003). Comparative American and Japanese tobacco smoke uptake parameters after overnight tobacco deprivation. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 27(6). 973–984. 9 indexed citations
13.
Domino, Edward F., Lisong Ni, Françis C. Colpaert, & Marc Marien. (2003). Effects of (±)-Idazoxan Alone and in Combination with L-DOPA Methyl Ester in MPTP-Induced Hemiparkinsonian Monkeys. PubMed. 9(5). 335–338. 14 indexed citations
14.
Domino, Edward F. & Lisong Ni. (2002). Clinical phenotyping strategies in selection of tobacco smokers for future genotyping studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 26(6). 1071–1078. 7 indexed citations
15.
Teter, Christian J., et al.. (2002). Comparative effects of tobacco smoking and nasal nicotine. European Journal of Clinical Pharmacology. 58(5). 309–314. 13 indexed citations
16.
Domino, Edward F., Satoshi Minoshima, Sally K. Guthrie, et al.. (2000). Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse. 38(3). 313–321. 83 indexed citations
17.
Domino, Edward F., et al.. (1999). Nicotine Alone and in Combination with l-DOPA Methyl Ester or the D2 Agonist N-0923 in MPTP-Induced Chronic Hemiparkinsonian Monkeys. Experimental Neurology. 158(2). 414–421. 25 indexed citations
18.
Domino, Edward F., et al.. (1998). Effects of Pramipexole on Contraversive Rotation and Functional Motor Impairments in 1-Methyl-4-phenyl1,2,3,6-tetrahydropyridine-Induced Chronic Hemiparkinsonian Monkeys. Journal of Pharmacology and Experimental Therapeutics. 287(3). 983–987. 5 indexed citations
19.
Domino, Edward F., et al.. (1998). Effects of Talipexole on Contraversive Rotation and Functional Impairment in MPTP-Induced Chronic Hemiparkinsonian Monkeys. The Japanese Journal of Pharmacology. 77(3). 227–233. 7 indexed citations
20.
Domino, Edward F. & Lisong Ni. (1998). Trihexyphenidyl Potentiation ofl-DOPA: Reduced Effectiveness Three Years Later in MPTP-Induced Chronic Hemiparkinsonian Monkeys. Experimental Neurology. 152(2). 238–242. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine Setiawan Breakdown of academic impact, for papers by Jacqueline Borg Breakdown of academic impact, for papers by Mayada Akil Breakdown of academic impact, for papers by Abigail G. Schindler Breakdown of academic impact, for papers by Jolanta Kucharska–Mazur Breakdown of academic impact, for papers by Mingkuan Lin Breakdown of academic impact, for papers by Christoph von der Goltz Breakdown of academic impact, for papers by Koichi Isogawa Breakdown of academic impact, for papers by Terrence Sills Breakdown of academic impact, for papers by P. Vivien Rekkas
Rankless by CCL
2026